Annals of Oncology 12:39-46, 2001
© 2001 European Society for Medical Oncology
research-article |
A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood
1Experimental Laboratory Medicine, University Hospital Gasthuisberg, Catholic University Leuven Belgium
2Laboratory of Experimental Oncology, University Hospital Gasthuisberg, Catholic University Leuven Belgium
3Multidisciplmary Breast Center, University Hospital Gasthuisberg, Catholic University Leuven Belgium
J Aerts, MD Experimental Laboratory Medicine CDG 7e VD Gasthuisberg Herestraat 49 3000 Leuven Belgium E-mailjoen.aerts{at}uz.kuleuven.ac.be
BACKGROUND: The detection of occult carcinoma cells in patients with breast cancer has been shown to predict disease recurrence and metastasis
MATERIALS AND METHODS: To improve on molecular detection of breast carcinoma cells in blood, we have developed a sensitive and quantitative assay using real-time quantitative RT–PCR identifying transcripts of the cytokeratin-19 (CK19) gene.
RESULTS: This real-time quantitative RT–PCR is sensitive, accurate and has a high reproducibihty within a wide dynamic range, which permits simultaneous quantitative analysis of samples with varying input concentrations Furthermore, the procedure offers several technical advantages over classic quantitative PCR methods (competitive RT–PCR, Northern blotting) such as decreased likelihood of contamination due to absence of post-PCR manipulations, high sample throughput because of absence of post-PCR processing time (no agarose gel electrophoresis). In this pilot study, we detected significantly elevated CKI9 transcript levels in <10% of the volunteers, in ±30% of stage I-IIIa patients preoperatively and in >70% of the and stage IV breast cancer patients.
CONCLUSIONS: Analyses using this real time quantitative RTPCR for CK.19 mRNA may prove to have clinical implications in the assessment of circulating tumour cells in peripheral blood, micrometastases in bone marrow or lymph nodes in breast cancer patients Application of this technique in a clinical population may improve diagnosis and monitoring of metastatic breast cancer and its validation is currently ongoing
breast cancer, cytokeratin, micrometastases, quantitative PCR, peripheral blood
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer J. Clin. Oncol., November 20, 2007; 25(33): 5287 - 5312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, M. Jiang, J. Zhao, and H. Ju Circulating Tumor Cells in Perioperative Esophageal Cancer Patients: Quantitative Assay System and Potential Clinical Utility Clin. Cancer Res., May 15, 2007; 13(10): 2992 - 2997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Apostolaki, M Perraki, A Pallis, V Bozionelou, S Agelaki, P Kanellou, A Kotsakis, E Politaki, K Kalbakis, A Kalykaki, et al. Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance Ann. Onc., May 1, 2007; 18(5): 851 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xi, M. C. Coello, V. R. Litle, S. Raja, W. E. Gooding, S. A. Yousem, T. El-Hefnawy, R. J. Landreneau, J. D. Luketich, and T. E. Godfrey A Combination of Molecular Markers Accurately Detects Lymph Node Metastasis in Non-Small Cell Lung Cancer Patients Clin. Cancer Res., April 15, 2006; 12(8): 2484 - 2491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Giribaldi, S. Procida, D. Ulliers, F. Mannu, R. Volpatto, G. Mandili, L. Fanchini, O. Bertetto, G. Fronda, L. Simula, et al. Specific Detection of Cytokeratin 20-Positive Cells in Blood of Colorectal and Breast Cancer Patients by a High Sensitivity Real-Time Reverse Transcriptase-Polymerase Chain Reaction Method J. Mol. Diagn., February 1, 2006; 8(1): 105 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xi, J. D. Luketich, S. Raja, W. E. Gooding, V. R. Litle, M. C. Coello, S. D. Finkelstein, M. L. Chestney, R. J. Landreneau, S. J. Hughes, et al. Molecular Staging of Lymph Nodes from Patients with Esophageal Adenocarcinoma Clin. Cancer Res., February 1, 2005; 11(3): 1099 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M Gilbey, D Burnett, R E Coleman, and I Holen The detection of circulating breast cancer cells in blood J. Clin. Pathol., September 1, 2004; 57(9): 903 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stathopoulou, A. Gizi, M. Perraki, S. Apostolaki, N. Malamos, D. Mavroudis, V. Georgoulias, and E. S. Lianidou Real-Time Quantification of CK-19 mRNA-Positive Cells in Peripheral Blood of Breast Cancer Patients Using the Lightcycler System Clin. Cancer Res., November 1, 2003; 9(14): 5145 - 5151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Ismail, W. Wynendaele, J. L. E. Aerts, R. Paridaens, L. Van Mellaert, J. Anne, R. Gaafar, N. Shakankiry, H. M. Khaled, M. R. Christiaens, et al. Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutions Ann. Onc., August 1, 2003; 14(8): 1241 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Xenidis, I. Vlachonikolis, D. Mavroudis, M. Perraki, A. Stathopoulou, N. Malamos, C. Kouroussis, S. Kakolyris, S. Apostolaki, N. Vardakis, et al. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer Ann. Onc., June 1, 2003; 14(6): 849 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Liu, M. Malott, and M. Leffak Multiple Functional Elements Comprise a Mammalian Chromosomal Replicator Mol. Cell. Biol., March 1, 2003; 23(5): 1832 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Weihrauch, E. Skibowski, T. C. Koslowsky, W. Voiss, D. Re, F. Kuhn-Regnier, C. Bannwarth, M. Siedek, V. Diehl, and H. Bohlen Immunomagnetic Enrichment and Detection of Micrometastases in Colorectal Cancer: Correlation With Established Clinical Parameters J. Clin. Oncol., November 1, 2002; 20(21): 4338 - 4343. [Abstract] [Full Text] [PDF]
|
|